Our capabilities in medicinal chemistry will help to accelerate and reduce the costs of synthesizing the NCEs. Based on the clients requirements we provide synthesis of various scaffolds, building blocks, reference & impurities compounds and novel reagents to biopharmaceutical companies. LAXAI also offers organic synthesis for compound libraries using flexible and scalable engagement models. We have the following capabilities:
Rapid Analoging
Building Blocks / Scaffolds synthesis
Metabolites and Impurities synthesis
Intermediate and Reference / Standard compounds synthesis
